JIMMY FONG: Open Payments
NPI 1619540358 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$490 in 20 payments from 7 companies in 2025. Trend: 2023 $448 · 2024 $880 · 2025 $490
Food & beverage: $420Education: $70
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 9 | $223 |
| AstraZeneca Pharmaceuticals LP | 5 | $101 |
| Astellas Pharma US Inc | 1 | $70 |
| JAZZ PHARMACEUTICALS INC. | 1 | $34 |
| Daiichi Sankyo Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $19 |
| Genentech USA, Inc. | 1 | $15 |
Products named: SCEMBLIX, CALQUENCE, Fabhalta, RYLAZE, VENCLEXTA, Vanflyta.
Industry payments across CA — which companies pay providers there.
